F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析

◆英語タイトル:F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH756FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:97
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

F. Hoffmann-La Roche Ltd (ROG) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides pharmaceuticals for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose and treat diseases. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists. Together with its subsidiaries and partners, the company has operations in various countries worldwide. Roche is headquartered in Basel, Switzerland.

F. Hoffmann-La Roche Ltd Key Recent Developments

Mar 16,2021: Roche announces annual general meeting 2021 results
Mar 15,2021: Roche to acquire GenMark Diagnostics for $1.8bn
Feb 25,2021: Weill Neurohub joins forces with Genentech and Roche to advance neuroscience research
Feb 04,2021: Roche reports solid results in 2020
Jan 25,2021: Roche renews partnership with Sysmex to deliver haematology testing solutions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
F. Hoffmann-La Roche Ltd – Key Facts
F. Hoffmann-La Roche Ltd – Key Employees
F. Hoffmann-La Roche Ltd – Key Employee Biographies
F. Hoffmann-La Roche Ltd – Major Products and Services
F. Hoffmann-La Roche Ltd – History
F. Hoffmann-La Roche Ltd – Company Statement
F. Hoffmann-La Roche Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
F. Hoffmann-La Roche Ltd – Business Description
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Africa, Australia and Oceania
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
F. Hoffmann-La Roche Ltd – Corporate Strategy
F. Hoffmann-La Roche Ltd – SWOT Analysis
SWOT Analysis – Overview
F. Hoffmann-La Roche Ltd – Strengths
F. Hoffmann-La Roche Ltd – Weaknesses
F. Hoffmann-La Roche Ltd – Opportunities
F. Hoffmann-La Roche Ltd – Threats
F. Hoffmann-La Roche Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
F. Hoffmann-La Roche Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 16, 2021: Roche announces annual general meeting 2021 results
Feb 25, 2021: Weill Neurohub joins forces with Genentech and Roche to advance neuroscience research
Feb 04, 2021: Roche reports solid results in 2020
Jan 25, 2021: Roche renews partnership with Sysmex to deliver haematology testing solutions
Jan 25, 2021: Sysmex and Roche renew agreement for global alliance
Jan 22, 2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform
Dec 17, 2020: Roche Diagnostics to create software development hub in Laval, Quebec
Dec 09, 2020: Roche to increase its payroll in Switzerland by 0.75 percent
Nov 17, 2020: Lead Pharma enters oral molecules development deal with Roche
Nov 16, 2020: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the eleventh time
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
F. Hoffmann-La Roche Ltd, Key Facts
F. Hoffmann-La Roche Ltd, Key Employees
F. Hoffmann-La Roche Ltd, Key Employee Biographies
F. Hoffmann-La Roche Ltd, Major Products and Services
F. Hoffmann-La Roche Ltd, History
F. Hoffmann-La Roche Ltd, Subsidiaries
F. Hoffmann-La Roche Ltd, Affiliate
F. Hoffmann-La Roche Ltd, Key Competitors
F. Hoffmann-La Roche Ltd, Ratios based on current share price
F. Hoffmann-La Roche Ltd, Annual Ratios
F. Hoffmann-La Roche Ltd, Annual Ratios (Cont...1)
F. Hoffmann-La Roche Ltd, Annual Ratios (Cont...2)
F. Hoffmann-La Roche Ltd, Interim Ratios
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
F. Hoffmann-La Roche Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務情報
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • Endo International Plc (ENDP)-医療機器分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • Acciona SA (ANA):電力:M&Aディール及び事業提携情報
    Summary Acciona SA (Acciona) is a provider of sustainable solutions for infrastructure and renewable energy projects. The company develops and manages infrastructure, renewable energy, water, and other facilities. Its operations cover the whole value chain, from design and construction to operation …
  • Gammon Infrastructure Projects Ltd (GAMMNINFRA):企業の財務・戦略的SWOT分析
    Gammon Infrastructure Projects Ltd (GAMMNINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報
    Summary Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, O …
  • Qisda Corporation
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • First Ship Lease Trust (D8DU):企業の財務・戦略的SWOT分析
    First Ship Lease Trust (D8DU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The E. W. Scripps Company:企業の戦略・SWOT・財務情報
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GS Retail Co., Ltd. (007070):企業の財務・戦略的SWOT分析
    GS Retail Co., Ltd. (007070) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tetra Technologies, Inc.
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Sutter Health:企業の戦略的SWOT分析
    Sutter Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Galen Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd, is a pharmaceutical company. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipa …
  • Naval Group:戦略・SWOT・企業財務分析
    Naval Group - Strategy, SWOT and Corporate Finance Report Summary Naval Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Argan Inc (AGX):企業の財務・戦略的SWOT分析
    Argan Inc (AGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Southern Travel Holdings Limited:企業の戦略・SWOT・財務分析
    Southern Travel Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Southern Travel Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆